SEC Tracker
Get the app

Privia Health Group PRVA

Privia Health Group Q1 FY24: net income $3.0M; diluted EPS $0.02

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Key figures from this report

These are the numbers Privia Health Group reported for Q1 FY24, the quarter ended Mar 31, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Net income$3.0MNo year-earlier figure tagged10-Q income statement, on EDGAR
  2. Diluted EPS$0.02No year-earlier figure tagged10-Q income statement, on EDGAR
  3. Cash and cash equivalents$351.1MNo year-earlier figure tagged10-Q balance sheet, on EDGAR
  4. Cash from operations−$33.1MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Privia Health Group files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8000 and related industry codes: the same peer list as the financial tables.

  1. GeneDx Holdings WGS public float $1.7B, Jun 30, 2025
  2. Omada Health OMDA public float $1.1B, Jun 30, 2025
  3. Pennant Group PNTG public float $989M, Jun 30, 2025
  4. LifeStance Health Group LFST public float $817M, Jun 30, 2025
  5. U S Physical Therapy USPH public float $737M, Jun 30, 2025